Gilead Sciences, Inc – Selloff Makes GILD Stock a Serious Bargain

The Gilead (GILD) stock price continues to take a beating after Merck gained FDA approval for a rival hep-C treatment. So what? Gilead's still a buy. More 

FDA Approves Merck Hepatitis C Drug

Merck has been given approval by the U.S. Food and Drug Administration for its Hepatitis C drug Zepatier for genotype 1 and 4 infections. More 

The 10 Best Healthcare Stocks to Buy Now

This list of the 10 best healthcare stocks to buy now includes extremely well-capitalized companies paying extraordinary dividends ... and trading for cheap. More 

5 Mouthwatering Stocks on Sale Now

Volatility? Yes, please! This is your opportunity to seize some great companies and stocks on sale! Here are 5 stocks to buy today More 

9 Biotech Stocks That Will Go Boom or Bust

A bunch of biotech stocks are knocking on the door of news that could prove to be very good or very bad. More 

81 Ways to Make Market Swings Work for You

During these times it pays to stay on top of profit opportunities. Today's blog post is a great place to start with these updated rankings More 

Gilead Sciences, Inc.: Attractively Priced Minus the Risk (GILD)

GILD stock's triple bottom and attractive valuation are best approached with a bull call spread. More